Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tipepidine for Adolescent Depression
NCT01835847Phase 2Completed
- Sponsor
- Chiba University
- Start
- Apr 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tipepidine hibenzate in major depressive disorder (MDD), sponsored by Chiba University. Primary endpoint: Children's Depression Rating Scale, Revised at 4 weeks. Started Apr 2013; status: completed.
02
Drugs
tipepidine hibenzate
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01835847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01835847.